Cadano, Jisza Lyn .
HRN: 15-21-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/26/2026
CEFUROXIME 500MG (TAB)
03/26/2026
04/02/2026
PO
500mg
BID
Thinly MSAF
Pending Pharmacy Acceptance
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: